£133.99

This is the most expensive it has ever been. Walk away.

£134 today · previous high £134 · all-time low £118

Elsevier Cancer Immunotherapy Volume 164 - Progress in Molecular Biology

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical
Generating forecast…
£133.99 £116.06 £119.97 £123.88 £127.80 £131.71 £135.62 01 August 2026 17 August 2026 03 September 2026 20 September 2026 07 October 2026
View at Amazon ↗

Price data last checked 23 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 68 days • 2 price levels

Days at Price
Current Price
64 days 4 days · current 0 16 32 48 64 £118 £134 Days at Price

Price Analysis

Most common price: £118 (64 days, 94.1%)

Price range: £118 - £134

Price levels: 2 different prices over 68 days

Description

Cancer Immunotherapy, Volume 164 in the Progress in Molecular Biology and Translational Science series, delivers comprehensive monographs on cutting-edge research in cancer immunotherapy approaches. This volume examines TNFR2 in cancer immunology and immunotherapy, explores pathways from the Hellstrom paradox towards cancer cure, and investigates CAR T-cell treatment of T-cell malignancy. Additional chapters cover immunotherapy of pancreatic cancer, cancer stem cell immunology and immunotherapy strategies, cytokine release syndrome mechanisms, tumour cell-based resistance to immune attack, and mushroom compounds in cancer immunotherapy. Essential reading for researchers and clinicians working in oncology, immunology, and translational medicine seeking current insights into advancing cancer treatment through immune-based interventions.

Key Features

Volume 164 focuses on TNFR2 in cancer immunology with detailed analysis of its role in immunotherapy applications.

Includes comprehensive coverage of CAR T-cell treatment approaches for T-cell malignancy management.

Examines cancer stem cell immunology and immunotherapy strategies for improved treatment outcomes.

Addresses cytokine release syndrome and tumour cell-based mechanisms of resistance to immune attack.

Part of the Progress in Molecular Biology and Translational Science series published by Academic Press.

Covers immunotherapy of pancreatic cancer and mushroom compounds in cancer immunotherapy research.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
12 August 2019
Listed Since
15 October 2018

Barcode

No barcode data available

Similar Products You Might Like

Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)
99% match

Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)

Elsevier

£128.99 25 Sep 2026
Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)
99% match

Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)

Elsevier

£79.99 25 Sep 2026
Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107
99% match

Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107

Elsevier

£92.99 24 Sep 2026
Academic Press Molecular Biology of Neurodegenerative Diseases
99% match

Academic Press Molecular Biology of Neurodegenerative Diseases

Elsevier

£133.99 07 Oct 2026
Autophagy Dysfunction in Alzheimer's Disease and Dementia
98% match

Autophagy Dysfunction in Alzheimer's Disease and Dementia

Elsevier

£114.99 05 Oct 2026
Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)
98% match

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Springer

£202.21 18 Aug 2026
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)
97% match

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)

Wiley

£181.99 18 Aug 2026
Neurodegenerative Disorders as Systemic Diseases
97% match

Neurodegenerative Disorders as Systemic Diseases

Springer

£107.85 23 Sep 2026
Mitochondrial Neuropathies: Volume 145 (International Review of Neurobiology, Volume 145)
97% match

Mitochondrial Neuropathies: Volume 145 (International Review of Neurobiology, Volume 145)

Elsevier

£133.99 07 Sep 2026
The Molecular and Clinical Pathology of Neurodegenerative Disease
97% match

The Molecular and Clinical Pathology of Neurodegenerative Disease

Academic Press

£70.99 24 Sep 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
97% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£73.70 28 Aug 2026
Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)
97% match

Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)

Humana

£99.94 06 Oct 2026
Omic Studies of Neurodegenerative Disease Part A Volume 121
97% match

Omic Studies of Neurodegenerative Disease Part A Volume 121

Elsevier

£128.00 21 Oct 2026
Omic Studies of Neurodegenerative Disease - Part B (Volume 122) (International Review of Neurobiology, Volume 122)
97% match

Omic Studies of Neurodegenerative Disease - Part B (Volume 122) (International Review of Neurobiology, Volume 122)

Elsevier

£142.77 21 Oct 2026
Elsevier Neurodegenerative Diseases Molecular and Cellular Basis
97% match

Elsevier Neurodegenerative Diseases Molecular and Cellular Basis

Elsevier

£69.27 16 Aug 2026
Neurodegenerative Diseases: Unifying Principles
97% match

Neurodegenerative Diseases: Unifying Principles

Oxford University Press

£132.46 30 Sep 2026
Precision Medicine in Neurodegenerative Disorders: Part II (Volume 193) (Handbook of Clinical Neurology, Volume 193)
97% match

Precision Medicine in Neurodegenerative Disorders: Part II (Volume 193) (Handbook of Clinical Neurology, Volume 193)

Elsevier

£178.19 02 Sep 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
97% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£105.50 24 Sep 2026
Neurodegenerative Diseases: 724 (Advances in Experimental Medicine and Biology)
97% match

Neurodegenerative Diseases: 724 (Advances in Experimental Medicine and Biology)

Springer

£92.00 19 Sep 2026
Handbook of Neurodegenerative Disorders
97% match

Handbook of Neurodegenerative Disorders

Springer

£188.07 19 Aug 2026
Neuroprotective Signal Transduction (Contemporary Neuroscience)
97% match

Neuroprotective Signal Transduction (Contemporary Neuroscience)

Humana

£81.46 22 Aug 2026
Progressive Cognitive Impairment & its Neuropathologic Correlates
97% match

Progressive Cognitive Impairment & its Neuropathologic Correlates

£162.75 19 Aug 2026
Practicing Neurology: What You Need to Know, What You Need to Do (Current Clinical Neurology)
97% match

Practicing Neurology: What You Need to Know, What You Need to Do (Current Clinical Neurology)

Humana

£58.14 09 Oct 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
97% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£136.75 21 Aug 2026